Eosinophilia in a patient with cyclical vomiting: a case report

Clinical and Molecular Allergy - Tập 2 - Trang 1-11 - 2004
Billy H Copeland1, Omolola O Aramide1, Salim A Wehbe1, S Matthew Fitzgerald1, Guha Krishnaswamy1
1Department of Internal Medicine, Division of Allergy and Immunology, East Tennessee State University, Johnson City, USA

Tóm tắt

Eosinophilic gastritis is related to eosinophilic gastroenteritis, varying only in regards to the extent of disease and small bowel involvement. Common symptoms reported are similar to our patient's including: abdominal pain, epigastric pain, anorexia, bloating, weight loss, diarrhea, ankle edema, dysphagia, melaena and postprandial nausea and vomiting. Microscopic features of eosinophilic infiltration usually occur in the lamina propria or submucosa with perivascular aggregates. The disease is likely mediated by eosinophils activated by various cytokines and chemokines. Therapy centers around the use of immunosuppressive agents and dietary therapy if food allergy is a factor. The patient is a 31 year old Caucasian female with a past medical history significant for ulcerative colitis. She presented with recurrent bouts of vomiting, abdominal pain and chest discomfort of 11 months duration. The bouts of vomiting had been reoccurring every 7–10 days, with each episode lasting for 1–3 days. This was associated with extreme weakness and cachexia. Gastric biopsies revealed intense eosinophilic infiltration. The patient responded to glucocorticoids and azathioprine. The differential diagnosis and molecular pathogenesis of eosinophilic gastritis as well as the molecular effects of glucocorticoids in eosinophilic disorders are discussed. The patient responded to a combination of glucocorticosteroids and azathioprine with decreased eosinophilia and symptoms. It is likely that eosinophil-active cytokines such as interleukin-3 (IL-3), granulocyte macrophage colony stimulating factor (GM-CSF) and IL-5 play pivotal roles in this disease. Chemokines such as eotaxin may be involved in eosinophil recruitment. These mediators are downregulated or inhibited by the use of immunosuppressive medications.

Tài liệu tham khảo

Rothenberg ME: Eosinophilia. N Engl J Med. 1998, 338: 1592-1600. 10.1056/NEJM199805283382206 Robinson J, Ahmed Z, Siddiqui A, Roy T, Berk S, Smith JK, Krishnaswamy G: A patient with persistent wheezing, sinusitis, elevated IgE, and eosinophilia. Ann Allergy Asthma Immunol. 1999, 82: 144-149. Simon MW, Simon NP: Cutaneous larva migrans. Pediatr Emerg Care. 2003, 19: 350-352. 10.1097/01.pec.0000092583.40174.71 Brenner MA, Patel MB: Cutaneous larva migrans: the creeping eruption. Cutis. 2003, 72: 111-115. Despommier D: Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003, 16: 265-272. 10.1128/CMR.16.2.265-272.2003 Bahna SL: Diagnosis of food allergy. Ann Allergy Asthma Immunol. 2003, 90: 77-80. Bock SA: Diagnostic evaluation. Pediatrics. 2003, 111: 1638-1644. Bahna SL: Clinical expressions of food allergy. Ann Allergy Asthma Immunol. 2003, 90: 41-44. Sampson HA: 9. Food allergy. J Allergy Clin Immunol. 2003, 111: S540-S547. 10.1067/mai.2003.134 Park HS, Kim HS, Jang HJ: Eosinophilic gastroenteritis associated with food allergy and bronchial asthma. J Korean Med Sci. 1995, 10: 216-219. Sicherer SH: Clinical aspects of gastrointestinal food allergy in childhood. Pediatrics. 2003, 111: 1609-1616. Nowak-Wegrzyn A, Sampson HA, Wood RA, Sicherer SH: Food protein-induced enterocolitis syndrome caused by solid food proteins. Pediatrics. 2003, 111: 829-835. Lhote F, Cohen P, Guillevin L: Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus. 1998, 7: 238-258. 10.1191/096120398678920055 Weller PF, Bubley GJ: The idiopathic hypereosinophilic syndrome. Blood. 1994, 83: 2759-2779. Brito-Babapulle F: The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol. 2003, 121: 203-223. Guajardo JR, Plotnick LM, Fende JM, Collins MH, Putnam PE, Rothenberg ME: Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pediatr. 2002, 141: 576-581. 10.1067/mpd.2002.127663 Meagher LC, Cousin JM, Seckl JR, Haslett C: Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol. 1996, 156: 4422-4428. Arlt W, Allolio B: Adrenal insufficiency. Lancet. 2003, 361: 1881-1893. 10.1016/S0140-6736(03)13492-7 Beishuizen A, Vermes I, Hylkema BS, Haanen C: Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet. 1999, 353: 1675-1676. 10.1016/S0140-6736(99)01346-X Angelis M, Yu M, Takanishi D, Hasaniya NW, Brown MR: Eosinophilia as a marker of adrenal insufficiency in the surgical intensive care unit. J Am Coll Surg. 1996, 183: 589-596. Bori R, Cserni G: Eosinophilic gastritis simulating gastric carcinoma. Orv Hetil. 2003, 144: 529-531. Owen DA: Gastritis and carditis. Mod Pathol. 2003, 16: 325-341. 10.1097/01.MP.0000062995.72390.14 Chaudhary R, Shrivastava RK, Mukhopadhyay HG, Diwan RN, Das AK: Eosinophilic gastritis – an unusual cause of gastric outlet obstruction. Indian J Gastroenterol. 2001, 20: 110. Kulkarni SH, Kshirsagar AY, Wader JV: Eosinophilic antral gastritis presenting as pyloric obstruction. J Assoc Physicians India. 1998, 46: 744. Scolapio JS, DeVault K, Wolfe JT: Eosinophilic gastroenteritis presenting as a giant gastric ulcer. Am J Gastroenterol. 1996, 91: 804-805. Ormeci N, Bayramoglu F, Tulunay O, Yerdel MA, Onbayrak A, Uzunalimoglu O: Cancer-like eosinophilic gastritis. Endoscopy. 1994, 26: 509. Esteve C, Resano A, Diaz-Tejeiro P, Fernandez-Benitez M: Eosinophilic gastritis due to Anisakis: a case report. Allergol Immunopathol (Madr). 2000, 28: 21-23. Stefanini GF, Addolorato G, Marsigli L, Foschi FG, D'Errico A, Scarani P, Bonvicini F, Bernardi M, Gasbarrini G: Eosinophilic gastroenteritis in a patient with large-cell anaplastic lung carcinoma: a paraneoplastic syndrome?. Ital J Gastroenterol. 1994, 26: 354-356. Lee JY, Medellin MV, Tumpkin C: Allergic reaction to gemfibrozil manifesting as eosinophilic gastroenteritis. South Med J. 2000, 93: 807-808. Lee M, Hodges WG, Huggins TL, Lee EL: Eosinophilic gastroenteritis. South Med J. 1996, 89: 189-194. Kita H: The eosinophil: a cytokine-producing cell?. J Allergy Clin Immunol. 1996, 97: 889-892. Moqbel R, Levi-Schaffer F, Kay AB: Cytokine generation by eosinophils. J Allergy Clin Immunol. 1994, 94: 1183-1188. Forssmann U, Uguccioni M, Loetscher P, Dahinden CA, Langen H, Thelen M, Baggiolini M: Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med. 1997, 185: 2171-2176. 10.1084/jem.185.12.2171 Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ: Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med. 1994, 179: 881-887. Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oettgen HC, Leder P, Luster AD: Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med. 1996, 2: 334-348. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ: Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995, 182: 1169-1174. Rankin SM, Conroy DM, Williams TJ: Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today. 2000, 6: 20-27. 10.1016/S1357-4310(99)01635-4 Desreumaux P, Bloget F, Seguy D, Capron M, Cortot A, Colombel JF, Janin A: Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology. 1996, 110: 768-774. Jaffe JS, James SP, Mullins GE, Braun-Elwert L, Lubensky I, Metcalfe DD: Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol. 1994, 14: 299-309. Hogan SP, Mishra A, Brandt EB, Foster PS, Rothenberg ME: A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc Natl Acad Sci USA. 2000, 97: 6681-6686. 10.1073/pnas.97.12.6681 Sicherer SH, Noone SA, Koerner CB, Christie L, Burks AW, Sampson HA: Hypoallergenicity and efficacy of an amino acid-based formula in children with cow's milk and multiple food hypersensitivities. J Pediatr. 2001, 138: 688-693. 10.1067/mpd.2001.113007 Justinich C, Katz A, Gurbindo C, Lepage G, Chad Z, Bouthillier L, Seidman E: Elemental diet improves steroid-dependent eosinophilic gastroenteritis and reverses growth failure. J Pediatr Gastroenterol Nutr. 1996, 23: 81-85. 10.1097/00005176-199607000-00014 Lonnkvist K, Hellman C, Lundahl , Hallden G, Hedlin G: Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. J Allergy Clin Immunol. 2001, 107: 812-817. 10.1067/mai.2001.114246 Tang RB, Chen SJ: Serum levels of eosinophil cationic protein and eosinophils in asthmatic children during a course of prednisolone therapy. Pediatr Pulmonol. 2001, 31: 121-125. 10.1002/1099-0496(200102)31:2<121::AID-PPUL1019>3.0.CO;2-T Evans CM, Jacoby DB, Fryer AD: Effects of dexamethasone on antigen-induced airway eosinophilia and M(2) receptor dysfunction. Am J Respir Crit Care Med. 2001, 163: 1484-1492. Uckan D, Hicsonmez G, Tunc B, Cetin M, Tezcan I, Tuncer M: The analysis of eosinophil and lymphocyte phenotype following single dose of high-dose methylprednisolone in two siblings with marked hypereosinophilia. Clin Lab Haematol. 2001, 23: 33-37. 10.1046/j.1365-2257.2001.00345.x Schleimer RP, Bochner BS: The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol. 1994, 94: 1202-1213. Barnes PJ, Adcock IM: Steroid resistance in asthma. QJM. 1995, 88: 455-468. Van Dellen RG, Lewis JC: Oral administration of cromolyn in a patient with protein-losing enteropathy, food allergy, and eosinophilic gastroenteritis. Mayo Clin Proc. 1994, 69: 441-444. Melamed I, Feanny SJ, Sherman PM, Roifman CM: Benefit of ketotifen in patients with eosinophilic gastroenteritis. Am J Med. 1991, 90: 310-314. Neustrom MR, Friesen C: Treatment of eosinophilic gastroenteritis with montelukast. J Allergy Clin Immunol. 1999, 104: 506. Daikh BE, Ryan CK, Schwartz RH: Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture. Ann Allergy Asthma Immunol. 2003, 90: 23-27. Schwartz DA, Pardi DS, Murray JA: Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci. 2001, 46: 1787-1790. 10.1023/A:1010682310928 Essayan DM, Krishnaswamy G, Oriente A, Lichtenstein LM, Huang SK: Differential regulation of antigen-induced IL-4 and IL-13 generation from T lymphocytes by IFN-alpha. J Allergy Clin Immunol. 1999, 103: 451-457. Krishnaswamy G, Smith JK, Srikanth S, Chi DS, Kalbfleisch JH, Huang SK: Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines. J Interferon Cytokine Res. 1996, 16: 819-827. Lowry PW, Franklin CL, Weaver AL, Szumlanski CL, Mays DC, Loftus EV, Tremaine WJ, Lipsky JJ, Weinshilboum RM, Sandborn WJ: Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut. 2001, 49: 656-664. 10.1136/gut.49.5.656 Tanigawa K, Sugiyama K, Matsuyama H, Nakao H, Kohno K, Komura Y, Iwanaga Y, Eguchi K, Kitaichi M, Takagi H: Mesalazine-induced eosinophilic pneumonia. Respiration. 1999, 66: 69-72. 10.1159/000029341 Baker DE: Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy. Rev Gastroenterol Disord. 2003, 3: 150-157. Fitzgerald KA, O'Neill LAJ, Gearing AJH, Callard RE: The Cytokine Facts Bood San Diego: Academic Press; 2001. Krishnaswamy G, Dube M, Counts M, Chi DS: Cytokines and the pathogenesis of atherosclerosis. In Advances in Cell Aging and Gerontology. Edited by: Hagen T, Mattson MP. 2002, 11: 79-126. 10.1016/S1566-3124(02)11027-3. Amsterdam: Elsevier Press, First.